COVID-19: investing in country capacity to bridge science, policy and action

Tanja Kuchenmüller¹, John C Reeder², Ludovic Reveiz³, Goran Tomson^{4

5}, Fadi El-Jardali^{6

7}, John N Lavis^{8

9}, Arash Rashidian¹⁰, Marge Reinap¹¹, John T Grove¹², Soumya Swaminathan¹³

Affiliations

¹ Department of Research for Health, World Health Organization, Geneve, Switzerland kuchenmullert@who.int.
² Department of Research for Health, World Health Organization, Geneve, Switzerland.
³ Department of Evidence and Intelligence for Action in Health and Incident Management System for COVID-19, WHO Regional Office for the Americas/Pan American Health Organization, Washington, District of Columbia, USA.
⁴ President's Office, Karolinska Institutet, Stockholm, Stockholm, Sweden.
⁵ Swedish Institute for Global Health Transformation, Royal Swedish Academy of Sciences, Stockholm, Sweden.
⁶ Knowledge to Policy (K2P) Center/WHO Collaborating Centre for Evidence-Informed Policymaking and Practice, American University of Beirut, Beirut, Lebanon.
⁷ Department of Health Management and Policy, American University of Beirut, Beirut, Lebanon.
⁸ McMaster Health Forum/WHO Collaborating Centre for Evidence-Informed Policy, McMaster University, Hamilton, Ontario, Canada.
⁹ Department of Health Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
¹⁰ Department of Science, Information and Dissemination, World Health Organisation Regional Office for the Eastern Mediterranean, Cairo, Egypt.
¹¹ Division of Country Health Policies and System, World Health Organization Regional Office for Europe, Copenhagen, Denmark.
¹² Department of Quality Assurance, Norms and Standards, World Health Organization, Geneve, Switzerland.
¹³ Office of Chief Scientist, World Health Organization, Geneve, Switzerland.

PMID: 33597281
PMCID: PMC7893206
DOI: 10.1136/bmjgh-2021-005012

Editorial

COVID-19: investing in country capacity to bridge science, policy and action

Tanja Kuchenmüller et al. BMJ Glob Health. 2021 Feb.

. 2021 Feb;6(2):e005012.

doi: 10.1136/bmjgh-2021-005012.

Authors

Affiliations

¹ Department of Research for Health, World Health Organization, Geneve, Switzerland kuchenmullert@who.int.
² Department of Research for Health, World Health Organization, Geneve, Switzerland.
³ Department of Evidence and Intelligence for Action in Health and Incident Management System for COVID-19, WHO Regional Office for the Americas/Pan American Health Organization, Washington, District of Columbia, USA.
⁴ President's Office, Karolinska Institutet, Stockholm, Stockholm, Sweden.
⁵ Swedish Institute for Global Health Transformation, Royal Swedish Academy of Sciences, Stockholm, Sweden.
⁶ Knowledge to Policy (K2P) Center/WHO Collaborating Centre for Evidence-Informed Policymaking and Practice, American University of Beirut, Beirut, Lebanon.
⁷ Department of Health Management and Policy, American University of Beirut, Beirut, Lebanon.
⁸ McMaster Health Forum/WHO Collaborating Centre for Evidence-Informed Policy, McMaster University, Hamilton, Ontario, Canada.
⁹ Department of Health Evidence and Impact, McMaster University, Hamilton, Ontario, Canada.
¹⁰ Department of Science, Information and Dissemination, World Health Organisation Regional Office for the Eastern Mediterranean, Cairo, Egypt.
¹¹ Division of Country Health Policies and System, World Health Organization Regional Office for Europe, Copenhagen, Denmark.
¹² Department of Quality Assurance, Norms and Standards, World Health Organization, Geneve, Switzerland.
¹³ Office of Chief Scientist, World Health Organization, Geneve, Switzerland.

PMID: 33597281
PMCID: PMC7893206
DOI: 10.1136/bmjgh-2021-005012

No abstract available

Keywords: COVID-19; health policy; health systems.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

References

1. Yang K. What can COVID-19 tell us about evidence-based management? Am Rev Public Adm 2020;50:706–12. 10.1177/0275074020942406 - DOI
1. Syed A, Mecci F, Mecci F. Covid-19 vaccination: heed the evidence. BMJ 2020;371:m4978. - PubMed
1. United Nations, Department of Economic and Social Affairs . 3UN/DESA Policy Brief #62: The COVID-19 pandemic: a wake-up call for better cooperation at the science–policy–society interface. United Nations, Department of Economic and Social Affairs [website]. Available: https://www.un.org/development/desa/dpad/publication/un-desa-policy-brie... [Accessed 28 Oct 2020].
1. Tseng V. Evidence for policy in the wake of COVID-19: short – medium – long term impacts. Available: https://blogs.lse.ac.uk/impactofsocialsciences/2020/05/22/evidence-for-p... [Accessed 28 Oct 2020].
1. El-Jardali F, Bou-Karroum L, Fadlallah R. Amplifying the role of knowledge translation platforms in the COVID-19 pandemic response. Health Res Policy Syst 2020;18:58. 10.1186/s12961-020-00576-y - DOI - PMC - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Grants and funding

001/WHO_/World Health Organization/International

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

COVID-19: investing in country capacity to bridge science, policy and action

Affiliations

COVID-19: investing in country capacity to bridge science, policy and action

Authors

Affiliations

Conflict of interest statement

References

Publication types

MeSH terms

Grants and funding

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical